Loading…
GE HealthCare Technologies Inc. is projected to rise to $74.90 by 2027, a +16% move from its current price of $64.70. GEHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $63.82 | $64.72 | $65.63 | +0.03% |
| Jul 14 | $63.47 | $64.74 | $66.03 | +0.06% |
| Jul 15 | $63.21 | $64.76 | $66.34 | +0.09% |
| Jul 16 | $62.99 | $64.78 | $66.61 | +0.12% |
| Jul 17 | $62.80 | $64.79 | $66.85 | +0.15% |
| Jul 18 | $62.64 | $64.81 | $67.07 | +0.17% |
| Jul 19 | $62.48 | $64.83 | $67.27 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $62.48 | $64.83 | $67.27 | +0.20% |
| Week 2 | $61.66 | $64.96 | $68.44 | +0.41% |
| Week 3 | $61.06 | $65.10 | $69.39 | +0.61% |
| Week 4 | $60.59 | $65.23 | $70.23 | +0.82% |
| Week 5 | $60.18 | $65.36 | $70.98 | +1.02% |
| Week 6 | $59.83 | $65.49 | $71.69 | +1.23% |
| Week 7 | $59.52 | $65.63 | $72.36 | +1.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GE HealthCare Technologies Inc. is a healthcare company that develops, manufactures, and markets products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. It operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The company has a strategic collaboration with DeepHealth and was formerly known as GE Healthcare Holding LLC. It changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GE HealthCare Technologies has a broad portfolio spanning molecular imaging, CT, MR, X-ray systems, ultrasound, interventional solutions, monitoring and digital solutions, and diagnostic agents through its PDx segment. These details reflect its diversified exposure across imaging, visualization, patient care, and diagnostic pharmaceuticals.
GE HealthCare Technologies Inc. (GEHC) currently trades at $61.59 per share and has a market cap of $28.02B. It is ranked 477 by market capitalization, highlighting its mid-cap positioning within the healthcare equipment and services space.
The near-term price action shows a bearish tilt, but the long-run forecast points to substantial upside through 2050, with rising average prices and meaningful ROIs across multiple years. The path remains data-driven and subject to market dynamics, but the forecast outlines a clear uptrend from the 2026 baseline.
Key forecast milestones include a 2027 avg of $69.77 with a 13.3% ROI, 2028 avg of $83.00 (34.8%), 2029 avg of $94.45 (53.4%), 2030 avg of $104.99 (70.5%), and continued gains through 2035 ($143.44 avg; 132.9% ROI). The trajectory extends to 2040 with an avg of $191.05 (210.2% ROI) and to 2050 with an avg of $404.44 (556.7% ROI), indicating a bullish long-term outlook.
A major floor 9.7% below — a decisive break under it would weaken the trend.
The nearest floor, 6.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 22.1% above — clearing it would confirm fresh momentum.
Key GEHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GEHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $64.76 | Sell | $64.75 | Sell |
| MA 10 | $64.91 | Sell | $64.66 | Buy |
| MA 20 | $64.18 | Buy | $64.40 | Buy |
| MA 50 | $63.23 | Buy | $65.18 | Sell |
| MA 100 | $68.82 | Sell | $68.02 | Sell |
| MA 200 | $73.83 | Sell | $71.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.74 | Neutral |
| Stoch RSI (14) | 73.13 | Neutral |
| CCI (20) | 32.06 | Neutral |
| Williams %R (14) | -20.70 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 1.54 | Buy |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 79.30 | Neutral |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 0.79 | Buy |
| Ultimate (7,14,28) | 62.70 | Neutral |
| Momentum (10) | -0.24 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 64.67 | Buy |
| ADX (14) | 8.77 | Neutral |
| ATR (14) | 0.73 | Info |
The 30-day technical picture shows a bearish sentiment, with RSI(14) at 40. The stock trades below the SMA50 of $65.40 and the SMA200 of $74.64, suggesting near-term headwinds.
Support sits at $60.76 and resistance at $66.01. The 30-day price range runs from $55.41 to $68.46, illustrating a relatively narrow window around the current price and the potential for short-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $59.49 | $64.70 | $85.65 | 0% | Neutral | |
| $61.35 | $74.90 | $95.62 | +16% | Neutral | |
| $69.58 | $86.56 | $113.48 | +34% | Bullish | |
| $80.02 | $101.07 | $135.34 | +56% | Bullish | |
| $88.67 | $113.52 | $154.73 | +75% | Bullish | |
| $90.99 | $117.91 | $163.27 | +82% | Bullish | |
| $93.28 | $122.24 | $171.66 | +89% | Bullish | |
| $98.45 | $130.37 | $185.46 | +102% | Bullish | |
| $102.63 | $137.26 | $197.59 | +112% | Bullish | |
| $117.87 | $159.13 | $231.62 | +146% | Bullish | |
| $147.58 | $207.81 | $316.99 | +221% | Bullish | |
| $299.83 | $452.81 | $740.38 | +600% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $59.49 | $64.70 | $76.41 | +0.00% |
| August 2026 | $56.52 | $66.15 | $79.10 | +2.24% |
| September 2026 | $56.49 | $66.43 | $80.06 | +0.43% |
| October 2026 | $55.86 | $65.97 | $80.03 | -0.70% |
| November 2026 | $57.16 | $67.74 | $82.63 | +2.68% |
| December 2026 | $58.76 | $69.86 | $85.65 | +3.13% |
Click any year to see its month-by-month GEHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GEHC to range from $59.49 to $85.65 through 2026. The $64.70 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GEHC price prediction for 2027 points to an average of $74.90 (low $61.35, high $95.62) — a potential gain of +16% on today's $64.70. A consolidation phase looks the most probable path here.
In 2028, GEHC is projected to trade between $69.58 and $113.48, averaging $86.56 — a potential gain of +34% from today's $64.70. That is up +16% on the projected 2027 average. Momentum favours further upside here.
GE HealthCare Technologies Inc.'s 2029 outlook centres on $101.07, within a $80.02 to $135.34 range. That is up +17% on the projected 2028 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GEHC could reach as high as $154.73, with a base case around $113.52 and support toward $88.67 — roughly +75% from $64.70. Momentum favours further upside here.
Expect GEHC to range from $90.99 to $163.27 through 2031. The $117.91 average target implies a +82% move from current prices. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The GEHC price prediction for 2032 points to an average of $122.24 (low $93.28, high $171.66) — a potential gain of +89% on today's $64.70. Momentum favours further upside here.
In 2033, GEHC is projected to trade between $98.45 and $185.46, averaging $130.37 — a potential gain of +102% from today's $64.70. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
GE HealthCare Technologies Inc.'s 2034 outlook centres on $137.26, within a $102.63 to $197.59 range. That is up +5% on the projected 2033 average. That marks a +112% change versus current levels. Momentum favours further upside here.
By 2035, GEHC could reach as high as $231.62, with a base case around $159.13 and support toward $117.87 — roughly +146% from $64.70. Buyers look set to stay in control over this stretch.
Expect GEHC to range from $147.58 to $316.99 through 2040. The $207.81 average target implies a +221% move from current prices. That is up +31% on the projected 2035 average. Momentum favours further upside here.
The GEHC price prediction for 2050 points to an average of $452.81 (low $299.83, high $740.38) — a potential gain of +600% on today's $64.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in GEHC today (≈ 15.455951 GEHC) could be worth
$6,998.58
+$5,998.58 (+600%) by 2050 · US Dollar
Based on the average projected GEHC price of $452.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GEHCwould be worth at today's price.
$1,000 invested in GEHC on Jul 10, 2025 (≈ 13.071895 GEHC) would be worth
$845.75
-$154.25 (-15.4%) today · 0.85× · US Dollar
Based on a GEHC entry price of $76.5 vs. today's $64.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $65.57 | $986.81 | -1.3% |
| 1 month ago | $63.76 | $1,014.74 | +1.5% |
| 3 months ago | $73.18 | $884.12 | -11.6% |
| 6 months ago | $86.9 | $744.53 | -25.5% |
| 1 year ago | $76.5 | $845.75 | -15.4% |
| All time (3.6y) ago | $60 | $1,078.33 | +7.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GEHC forecast.
Our base-case forecast reaches $130.00 around 2033.
Implied market cap at $130.00: $59.14B
The multi-year forecast paints a bullish path beyond 2026, with 2027 remaining neutral and the trend turning strongly positive from 2028 onward. The average price climbs from $83.00 in 2028 to $191.05 by 2040 and reaches $404.44 in 2050, with ROIs reaching as high as 556.7% in 2050. This implies meaningful upside if the projected path plays out, though the forecast notes these are estimates and not guarantees.
Risks to the forecast include market conditions, company performance, and broader industry dynamics. While the long-term numbers point to substantial upside, the near-term (2026-2027) shows neutral sentiment, underscoring that uncertainty remains and that outcomes can diverge from the projections.
Tap a question to reveal the answer.
Avg $104.99, min $81.96, max $143.25; ROI 70.5%; sentiment Bullish.
Forecast shows bullish sentiment from 2028 onward with rising averages and ROI up to 556.7% by 2050, though 2026-2027 are Neutral; forecasts are estimates, not guarantees.
The 2035 max is $208.90, the 2040 max is $291.55, and the 2050 max is $661.50; these suggest the possibility of surpassing $200 in the forecast, but are not guarantees.
Current price is $61.59; Market cap is $28.02B.
Bearish sentiment with RSI 40; price below SMA50 ($65.40) and SMA200 ($74.64); support at $60.76 and resistance at $66.01; 30-day range $55.41–$68.46.
GE HealthCare Technologies Inc. Community Discussion
0Share your GE HealthCare Technologies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.